Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  6. Financials
    603882   CNE100002VW1

GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

(603882)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 10 20223 45358 87052 780--
Entreprise Value (EV)1 10 20223 45357 69650 35648 60747 172
P/E ratio 43,7x58,2x39,2x28,3x29,7x26,2x
Yield -0,27%0,26%0,42%0,37%0,41%
Capitalization / Revenue 2,25x4,45x7,14x4,70x4,85x4,35x
EV / Revenue 2,25x4,45x7,00x4,49x4,47x3,89x
EV / EBITDA 17,7x29,5x26,6x18,6x19,2x16,6x
Price to Book 5,35x10,3x15,5x9,36x7,24x5,81x
Nbr of stocks (in thousands) 457 885457 885459 488463 959--
Reference price (CNY) 22,351,2128114114114
Announcement Date 04/25/201904/28/202004/19/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 4 5255 2698 24411 22310 87212 127
EBITDA1 5767942 1662 7032 5362 846
Operating profit (EBIT)1 3124841 8172 4372 2452 484
Operating Margin 6,89%9,19%22,0%21,7%20,6%20,5%
Pre-Tax Profit (EBT)1 3214961 8102 4802 3392 601
Net income1 2334021 5101 8901 8592 138
Net margin 5,16%7,64%18,3%16,8%17,1%17,6%
EPS2 0,510,883,274,023,834,35
Dividend per Share2 -0,140,330,470,420,46
Announcement Date 04/25/201904/28/202004/19/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales1 2 7773 1622 5172 8042 7542 703
EBITDA ------
Operating profit (EBIT)1 619767454650650650
Operating Margin 22,3%24,3%18,0%23,2%23,6%24,0%
Pre-Tax Profit (EBT) ------
Net income ------
Net margin ------
EPS2 1,111,310,901,011,011,01
Dividend per Share ------
Announcement Date 08/16/202110/25/2021----
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 --1 1742 4244 1735 608
Leverage (Debt / EBITDA) ---0,54x-0,90x-1,65x-1,97x
Free Cash Flow ------
ROE (Net Profit / Equities) 13,0%19,2%50,1%35,9%25,5%22,1%
Shareholders' equity1 1 8022 0923 0165 2657 2929 674
ROA (Net Profit / Asset) -9,63%27,4%23,8%19,0%15,1%
Assets1 -4 1775 5177 9329 76914 130
Book Value Per Share2 4,164,978,2412,215,719,6
Cash Flow per Share2 1,161,443,314,574,944,53
Capex1 -271540416368236
Capex / Sales -5,13%6,55%3,71%3,38%1,95%
Announcement Date 04/25/201904/28/202004/19/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 52 779 950 244
Capitalization (USD) 8 257 317 894
Net sales (CNY) 8 243 763 520
Net sales (USD) 1 290 610 642
Number of employees 10 714
Sales / Employee (CNY) 769 438
Sales / Employee (USD) 120 460
Free-Float 54,2%
Free-Float capitalization (CNY) 28 612 444 575
Free-Float capitalization (USD) 4 476 359 858
Avg. Exchange 20 sessions (CNY) 388 996 404
Avg. Exchange 20 sessions (USD) 60 899 721
Average Daily Capital Traded 0,74%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA